Editorial Commentary
ROS1 fusion-positive non-small cell lung cancer—repotrectinib as a new treatment option
Translational Cancer Research
2025;
14
(6)
:3272-3276
.
(30 June 2025)
How to treat systemic recurrences following adjuvant immunotherapy
Translational Cancer Research
2025;
14
(6)
:3277-3280
.
(30 June 2025)
Advances in genomic biomarkers for lethal metastatic castration-resistant prostate cancer
Translational Cancer Research
2025;
14
(6)
:3281-3285
.
(30 June 2025)
Trastuzumab deruxtecan: expanding the role of HER2-targeted therapy in solid tumors
Translational Cancer Research
2025;
14
(6)
:3286-3291
.
(30 June 2025)
Key considerations for interpreting patient-reported outcomes in deep inferior epigastric artery perforator flap reconstruction with post-mastectomy radiotherapy
Translational Cancer Research
2025;
14
(6)
:3292-3294
.
(30 June 2025)
FLAURA2: evidence for escalated first-line therapy in EGFR-mutated non-small cell lung cancer with central nervous system metastases
Translational Cancer Research
2025;
14
(6)
:3295-3301
.
(30 June 2025)
Original Article
Prognostic factor analysis and nomogram construction for elderly patients with stages III and IV epithelial ovarian cancer: a study based on the SEER database
Translational Cancer Research
2025;
14
(6)
:3302-3318
.
(30 June 2025)
Hepatitis B virus core/capsid protein induces hepatocellular carcinoma progression via long non-coding RNA KCNQ1OT1/miR-335-5p/CDC7 axis
Translational Cancer Research
2025;
14
(6)
:3319-3335
.
(30 June 2025)
Construction of a novel disulfidptosis-associated lncRNAs signature for risk features and immunotherapy in breast cancer
Translational Cancer Research
2025;
14
(6)
:3336-3350
.
(30 June 2025)
Carfilzomib plus pomalidomide and dexamethasone as salvage therapy in patients with relapsed or refractory multiple myeloma in China: a retrospective study
Translational Cancer Research
2025;
14
(6)
:3351-3358
.
(30 June 2025)
Fusobacterium nucleatum and IL-32 co-predict nodal metastasis preoperatively in head and neck cancer
Translational Cancer Research
2025;
14
(6)
:3359-3372
.
(30 June 2025)
Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy in patients with resectable esophageal squamous cell carcinoma: a systematic review and meta-analysis
Translational Cancer Research
2025;
14
(6)
:3373-3399
.
(30 June 2025)
Predictive value of CT-based imaging model for BRAF gene mutation in patients with colorectal cancer: a retrospective study
Translational Cancer Research
2025;
14
(6)
:3400-3409
.
(30 June 2025)
Ramifications of lymph node metastasis in patients with pT1 colorectal cancer
Translational Cancer Research
2025;
14
(6)
:3410-3419
.
(30 June 2025)
Construction of a prognostic model for lung adenocarcinoma based on disulfidptosis-related lncRNAs
Translational Cancer Research
2025;
14
(6)
:3420-3437
.
(30 June 2025)
Blocking of CDC25B suppresses sarcoma progression via arresting cell cycle
Translational Cancer Research
2025;
14
(6)
:3438-3451
.
(30 June 2025)
Construction of molecular subtypes and prognostic model for breast cancer based on sulfur metabolism-related genes
Translational Cancer Research
2025;
14
(6)
:3452-3470
.
(30 June 2025)
Guanine monophosphate synthase-mediated nuclear and mitochondrial communication in the progression of gastric cancer
Translational Cancer Research
2025;
14
(6)
:3471-3489
.
(30 June 2025)
Outcomes of radiotherapy combined with immune checkpoint inhibitors in locally advanced unresectable esophageal squamous cell carcinoma: a retrospective analysis
Translational Cancer Research
2025;
14
(6)
:3490-3499
.
(30 June 2025)
Retrospective prognostic evaluation and single-cell transcriptomic analyses of non-small cell lung carcinoma with malignant pleural effusion
Translational Cancer Research
2025;
14
(6)
:3500-3519
.
(30 June 2025)
FBXO32 promotes gastric cancer progression by regulating NME1
Translational Cancer Research
2025;
14
(6)
:3520-3531
.
(30 June 2025)
Determining the optimal surgical margin using whole scene pathology and molecular surgical margin analysis in colorectal cancer radical surgery—a cross-sectional study
Translational Cancer Research
2025;
14
(6)
:3532-3541
.
(30 June 2025)
Development and validation of an MBD3/UHRF1 methylation-regulator-based prognostic model for pancreatic cancer survival
Translational Cancer Research
2025;
14
(6)
:3542-3553
.
(30 June 2025)
Potential biomarker for screening nasopharyngeal carcinoma: three-microRNA panel in serum
Translational Cancer Research
2025;
14
(6)
:3554-3564
.
(30 June 2025)
Competing risk analysis of surgical resection vs. radiofrequency ablation in early-stage small hepatocellular carcinoma: a SEER-based study
Translational Cancer Research
2025;
14
(6)
:3565-3576
.
(30 June 2025)
Risk factors analysis for percutaneous endoscopic gastrostomy in patients with oral cancer: a retrospective study
Translational Cancer Research
2025;
14
(6)
:3577-3586
.
(30 June 2025)
Knockdown of MIR205HG prevents cell proliferation, migration and invasion through autophagy and ferroptosis pathways in lung adenocarcinoma
Translational Cancer Research
2025;
14
(6)
:3587-3598
.
(30 June 2025)
Transarterial chemoembolization in combination with lenvatinib and sintilimab for the treatment of unresectable hepatocellular carcinoma with arterioportal shunts: a retrospective analysis
Translational Cancer Research
2025;
14
(6)
:3599-3610
.
(30 June 2025)
A predictive model based on immune related genes for diffuse large B cell lymphoma (DLBCL)
Translational Cancer Research
2025;
14
(6)
:3611-3626
.
(30 June 2025)
Effects of radiotherapy, chemotherapy, and chemoradiotherapy on survival outcomes in patients with gallbladder carcinoma: a real population-based study
Translational Cancer Research
2025;
14
(6)
:3627-3641
.
(30 June 2025)
Pre-radiotherapy frailty and associated determinants in elderly patients with thoracic tumors
Translational Cancer Research
2025;
14
(6)
:3642-3653
.
(30 June 2025)
Proteomics-based prognostic signature in colon adenocarcinoma patients with familial adenomatous polyposis
Translational Cancer Research
2025;
14
(6)
:3654-3669
.
(30 June 2025)
A retrospective study using the Surveillance Epidemiology and End Results (SEER) database to predict risk and prognostic factors for lung metastasis in cervical carcinoma: nomogram development and validation
Translational Cancer Research
2025;
14
(6)
:3670-3689
.
(30 June 2025)
CNTN1 promotes cell proliferation and metastasis in ovarian cancer through PSEN1
Translational Cancer Research
2025;
14
(6)
:3690-3701
.
(30 June 2025)
Vitamin D-regulated miRNA expression in tumoral and normal adjacent tissue of localized gastric cancer patients: the impact on survival and time to relapse
Translational Cancer Research
2025;
14
(6)
:3702-3713
.
(30 June 2025)
Polyamine metabolism and immune related genes as prognostic features in breast cancer: a novel risk model approach
Translational Cancer Research
2025;
14
(6)
:3714-3729
.
(30 June 2025)
Integrated single-cell and bulk RNA sequencing reveals prognostic and immunotherapy-associated myofibroblastic cancer-associated fibroblast subtypes in head and neck squamous cell carcinoma
Translational Cancer Research
2025;
14
(6)
:3730-3745
.
(30 June 2025)
Systemic immune response induced by radiofrequency ablation versus microwave ablation at varying powers in murine models of hepatocellular carcinoma
Translational Cancer Research
2025;
14
(6)
:3746-3757
.
(30 June 2025)
Theaflavin inhibits the malignant phenotype of human anaplastic thyroid cancer 8305C cells by regulating lipid metabolism via PI3K/AKT signaling
Translational Cancer Research
2025;
14
(6)
:3758-3771
.
(30 June 2025)
The effect and related mechanisms of RAC1 GTP on radiotherapy for hepatocellular carcinoma
Translational Cancer Research
2025;
14
(6)
:3772-3784
.
(30 June 2025)
Silencing PPA1 promotes the survival of non-small cell lung cancer A549 cells under glucose-starved conditions
Translational Cancer Research
2025;
14
(6)
:3785-3796
.
(30 June 2025)
Identification of glycolysis-related genes and analysis of potential prognostic clinical application in oral squamous cell carcinoma
Translational Cancer Research
2025;
14
(6)
:3797-3811
.
(30 June 2025)
Development of a KRP-based pH-responsive drug delivery system for solid tumors
Translational Cancer Research
2025;
14
(6)
:3812-3821
.
(30 June 2025)
Brief Report
Investigation of effects of CFI-400945 and ionizing radiation on DNA damage response in triple-negative breast cancer
Translational Cancer Research
2025;
14
(6)
:3822-3832
.
(30 June 2025)
Review Article
Diagnosis and multimodality treatment of primary malignant tracheal tumors
Translational Cancer Research
2025;
14
(6)
:3833-3845
.
(30 June 2025)
Development and clinical applications of liquid biopsy assays in cancer screening
Translational Cancer Research
2025;
14
(6)
:3846-3859
.
(30 June 2025)
Current and evolving practices of carbohydrate antigens in gastric cancer: a narrative review
Translational Cancer Research
2025;
14
(6)
:3860-3873
.
(30 June 2025)
Erratum
Erratum: MT-12 inhibits the growth and metastasis of bladder cancer cells via suppressing tumor angiogenesis in vivo and in vitro
Translational Cancer Research
2025;
14
(6)
:3874-3876
.
(30 June 2025)
Erratum: Impact of apatinib in combination with osimertinib on EGFR T790M-positive lung adenocarcinoma
Translational Cancer Research
2025;
14
(6)
:3877-3879
.
(30 June 2025)
Erratum: CK1α-targeting inhibits primary and metastatic colorectal cancer in vitro, ex vivo, in cell-line-derived and patient-derived tumor xenograft mice models
Translational Cancer Research
2025;
14
(6)
:3880-3881
.
(30 June 2025)
Erratum: CD276 (B7H3) improve cancer stem cells formation in cervical carcinoma cell lines
Translational Cancer Research
2025;
14
(6)
:3882
.
(30 June 2025)
